Suppr超能文献

肾移植术后儿童的循环钙化抑制剂与血管特性

Circulating calcification inhibitors and vascular properties in children after renal transplantation.

作者信息

van Summeren Marieke J H, Hameleers Jeroen M, Schurgers Leon J, Hoeks Arnold P G, Uiterwaal Cuno S P M, Krüger Thilo, Vermeer Cees, Kuis Wietse, Lilien Marc R

机构信息

Department of Pediatric Immunology, University Medical Centre Utrecht, Lundlaan 6, Room KE.04.133.1, 3584 EA Utrecht, The Netherlands.

出版信息

Pediatr Nephrol. 2008 Jun;23(6):985-93. doi: 10.1007/s00467-007-0743-4.

Abstract

Pediatric transplant patients are known to have vascular abnormalities. The calcification inhibitors matrix Gla protein (MGP) and fetuin-A play an important role in the pathophysiology of vascular calcification. In the cross-sectional study reported here, we examined the circulating levels of fetuin-A and MGP in children after renal transplantation compared to healthy children and the association of these factors with vascular properties of the carotid artery. Levels of MGP and fetuin-A together with vascular properties of the carotid artery were determined in 29 pediatric renal transplant recipients and 54 healthy controls. The level of fetuin-A was decreased in the transplant group relative to the control group (P=0.005), whereas the level of MGP (both non-phosphorylated MGP and non-carboxylated MGP) did not differ between groups. The intima-media thickness (P<0.001) and the elasticity (P=0.002) of the carotid artery were significantly increased in children after renal transplantation compared to healthy children. No associations between vascular parameters and calcification inhibitors were found in either group. Circulating levels of MGP and fetuin-A could not be identified as independent predictors of vascular stiffness or other carotid artery parameters in pediatric renal transplant recipients. Future prospective studies in pediatric ESRD and transplant patients are needed to learn more about the role of calcification inhibitors in relation to the prevention of vascular damage.

摘要

已知小儿移植患者存在血管异常。钙化抑制剂基质Gla蛋白(MGP)和胎球蛋白-A在血管钙化的病理生理学中起重要作用。在本文报道的横断面研究中,我们检测了肾移植术后儿童与健康儿童相比循环中胎球蛋白-A和MGP的水平,以及这些因素与颈动脉血管特性的相关性。测定了29例小儿肾移植受者和54例健康对照者的MGP和胎球蛋白-A水平以及颈动脉的血管特性。与对照组相比,移植组胎球蛋白-A水平降低(P = 0.005),而两组间MGP(非磷酸化MGP和非羧化MGP)水平无差异。与健康儿童相比,肾移植术后儿童的颈动脉内膜中层厚度(P < 0.001)和弹性(P = 0.002)显著增加。两组中均未发现血管参数与钙化抑制剂之间存在关联。在小儿肾移植受者中,循环中MGP和胎球蛋白-A水平不能被确定为血管僵硬度或其他颈动脉参数的独立预测因子。需要对小儿终末期肾病和移植患者进行未来的前瞻性研究,以进一步了解钙化抑制剂在预防血管损伤方面的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验